MyFinsight
Home
Blog
About
Contact
Download
Download image
Investments
$3,297M
(-24.24%↓ Y/Y)
Cash and cash
equivalents
$1,908M
(17.56%↑ Y/Y)
Prepaid expenses and
other current assets
$348M
(-40.51%↓ Y/Y)
Inventory
$146M
(14.06%↑ Y/Y)
Accounts receivable, net
$71M
(-8.97%↓ Y/Y)
Total current assets
$5,770M
(-14.72%↓ Y/Y)
Investments, non-current
$2,251M
(-6.91%↓ Y/Y)
Property, plant and
equipment, net
$2,086M
(-5.70%↓ Y/Y)
Right-of-use assets,
operating leases
$706M
(-6.12%↓ Y/Y)
Other non-current
assets
$675M
(21.40%↑ Y/Y)
Total assets
$11,488M
(-9.57%↓ Y/Y)
Total liabilities and
stockholders equity
$11,488M
(-9.57%↓ Y/Y)
Total stockholders
equity
$7,408M
(-26.41%↓ Y/Y)
Total liabilities
$4,080M
(54.66%↑ Y/Y)
Retained earnings
$5,880M
(-35.20%↓ Y/Y)
Additional paid-in capital
$1,503M
(53.05%↑ Y/Y)
Accumulated other
comprehensive income
$25M
(150.00%↑ Y/Y)
Total current
liabilities
$2,395M
(49.31%↑ Y/Y)
Operating lease
liabilities, non-current
$645M
(-3.30%↓ Y/Y)
Long-term debt
$590M
Other non-current
liabilities
$283M
(3.28%↑ Y/Y)
Deferred revenue,
non-current
$154M
(165.52%↑ Y/Y)
Financing lease
liabilities, non-current
$13M
(-62.86%↓ Y/Y)
Accrued liabilities
$1,912M
(91.01%↑ Y/Y)
Other current
liabilities
$220M
(-12.70%↓ Y/Y)
Accounts payable
$161M
(-28.76%↓ Y/Y)
Deferred revenue
$102M
(-18.40%↓ Y/Y)
Back
Back
Balance Sheet
Master Final R&D Day 2021 Slides (09
Moderna, Inc. (MRNA)
Master Final R&D Day 2021 Slides (09
source: myfinsight.com
Moderna, Inc. (MRNA)